Differential effects of isoflurane on human median nerve somatosensory evoked potentials.
The effect of isoflurane on median nerve somatosensory evoked potentials (MN-SSEPs) was studied in 15 patients. Anesthesia was induced with thiamylal and maintained with oxygen and isoflurane. MN-SSEPs were recorded in awake patients and after achieving 0.5, 1.0, 1.5, and 2.0% stable end-tidal concentrations of isoflurane. Peak latencies and amplitudes of EP, N13, and N20 and conduction times EP-N13, N13-N20, and EP-N20 were measured. Peak latencies of all components increased after all concentrations of isoflurane compared with control values. N20 peak latencies after 1% and 1.5% isoflurane differed significantly, whereas EP and N13 latencies showed no significant difference. No significant change in conduction time EP-N13 resulted from 1% and 1.5% concentrations of isoflurane compared with control values. Isoflurane increased conduction time N13-N20 significantly when compared with control values, and this increase was dose related. Amplitude of EP and N13 did not show significant change with 1% and 1.5% isoflurane when compared with control values. Amplitude of N20 decreased significantly following isoflurane anesthesia compared with control values, and the difference between 1% and 1.5% isoflurane recordings was also statistically significant. N20 was not discernible in one out of 14 patients after 1.5% and in three out of ten patients after 2% isoflurane. These results indicate that subcortical potentials are less affected by isoflurane anesthesia than cortical potentials. Amplitude reduction of cortical potentials was more noticeable than either prolongation of peak latency or conduction time.(ABSTRACT TRUNCATED AT 250 WORDS)
D005073:Evoked Potentials, Somatosensory / Q000187:drug effects*; D006801:Humans; D007530:Isoflurane / Q000494:pharmacology*; D008475:Median Nerve / Q000187:drug effects*; D010100:Oxygen; D013840:Thiamylal
D013840:Thiamylal; D007530:Isoflurane; D010100:Oxygen